Home › Targets › FXN

FXN (4 companies · 4 programs)

Companies with an active program directed at FXN.

Larimar Therapeutics, Inc. LRMR

nomlabofusp — Friedreich's Ataxia Phase 3

Lexeo Therapeutics, Inc. LXEO

LX2006 — Friedreich Ataxia Cardiomyopathy Phase 1

Solid Biosciences Inc. SLDB

SGT-212 — Friedreich's Ataxia Phase 1

Voyager Therapeutics, Inc. VYGR

frataxin gene therapy — Friedreich's Ataxia Preclinical